** Bruker Corp's BRKR.O shares down 13% at $28.91 in afternoon trading on Weds after medical equipment maker late Tues commenced $600 mln 3-yr mandatory convertible preferred stock offering
** BRKR shares on course for biggest daily pct drop since COVID pandemic onset in Mar 2020
**
Massachusetts-based Bruker said intends to use net proceeds to strengthen its balance sheet by fully repaying term loan due Dec 2026, and other outstanding debt
** Convertible preferred stock offerings allow investors to purchase preferred shares, which typically pay higher dividends than a firm's common stock
** As of last close, BRKR's stock had 0.6% annualized dividend yield
** JP Morgan and BofA are joint bookrunners for the offering
** Including move on the session, shares down ~51% YTD
** About 8.5 mln shares have traded so far, quadruple their 10-DMA volume, per LSEG data
** Of 14 analysts covering BRKR, recommendation breakdown is 6 "strong buy" or "buy", 7 "hold" and 1 "sell" and median PT is $43 - LSEG
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))